Primary |
Hypertension |
52.5% |
Product Used For Unknown Indication |
14.0% |
Essential Hypertension |
12.6% |
Drug Use For Unknown Indication |
10.5% |
Diabetes Mellitus |
1.2% |
Prophylaxis |
1.0% |
Atrial Fibrillation |
0.8% |
Hyperuricaemia |
0.8% |
Rheumatoid Arthritis |
0.8% |
Type 2 Diabetes Mellitus |
0.8% |
Hyperlipidaemia |
0.7% |
Pain |
0.6% |
Self Mutilation |
0.6% |
Interstitial Lung Disease |
0.5% |
Dyslipidaemia |
0.5% |
Gastric Ulcer |
0.5% |
Insomnia |
0.5% |
Benign Prostatic Hyperplasia |
0.4% |
Blood Pressure Increased |
0.4% |
Gastritis Prophylaxis |
0.4% |
|
Syncope |
10.0% |
Weight Decreased |
9.7% |
Renal Impairment |
7.4% |
Hypotension |
7.1% |
Renal Failure Acute |
6.2% |
Vomiting |
6.2% |
Hypoglycaemia |
5.9% |
Thrombocytopenia |
5.9% |
Platelet Count Decreased |
4.4% |
Liver Disorder |
4.1% |
Shock |
4.1% |
Cerebral Infarction |
3.8% |
Hepatitis Acute |
3.8% |
Toxic Epidermal Necrolysis |
3.8% |
Blood Pressure Decreased |
3.2% |
Malabsorption |
2.9% |
Malaise |
2.9% |
Orthostatic Hypotension |
2.9% |
Pneumonia |
2.9% |
Blood Pressure Increased |
2.6% |
|
Secondary |
Hypertension |
38.7% |
Drug Use For Unknown Indication |
14.9% |
Product Used For Unknown Indication |
11.7% |
Diabetes Mellitus |
4.0% |
Dyslipidaemia |
4.0% |
Rheumatoid Arthritis |
3.9% |
Type 2 Diabetes Mellitus |
2.7% |
Back Pain |
2.5% |
Infection Prophylaxis |
2.5% |
Pain |
2.5% |
Essential Hypertension |
2.0% |
Bursitis |
1.3% |
Depression |
1.3% |
Metastatic Renal Cell Carcinoma |
1.3% |
Gastritis Prophylaxis |
1.2% |
Hiv Infection |
1.2% |
Thyroid Function Test Abnormal |
1.2% |
Hypercholesterolaemia |
1.2% |
Headache |
1.1% |
Hyperlipidaemia |
1.0% |
|
Renal Failure Acute |
11.5% |
Circulatory Collapse |
8.3% |
Hyperkalaemia |
7.8% |
Death |
7.4% |
Hypertensive Emergency |
6.9% |
Respiratory Arrest |
6.9% |
Completed Suicide |
6.5% |
Overdose |
4.1% |
Rash |
4.1% |
Shock |
4.1% |
Liver Disorder |
3.7% |
Liver Injury |
3.7% |
Vomiting |
3.7% |
Hyponatraemia |
3.2% |
Sudden Hearing Loss |
3.2% |
Syncope |
3.2% |
Toxicity To Various Agents |
3.2% |
Drug Eruption |
2.8% |
Hypertension |
2.8% |
Renal Failure |
2.8% |
|
Concomitant |
Hypertension |
21.5% |
Product Used For Unknown Indication |
15.9% |
Drug Use For Unknown Indication |
14.8% |
Prophylaxis |
7.5% |
Rheumatoid Arthritis |
7.1% |
Hepatitis C |
4.2% |
Diabetes Mellitus |
4.1% |
Aplastic Anaemia |
3.5% |
Type 2 Diabetes Mellitus |
2.7% |
Pain |
2.2% |
Constipation |
1.9% |
Hiv Infection |
1.9% |
Insomnia |
1.9% |
Hyperlipidaemia |
1.9% |
Infection Prophylaxis |
1.8% |
Atrial Fibrillation |
1.7% |
Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
Hypercholesterolaemia |
1.4% |
Osteoporosis |
1.3% |
Angina Pectoris |
1.3% |
|
Rhabdomyolysis |
9.0% |
Renal Impairment |
8.3% |
Vomiting |
7.6% |
Renal Failure Acute |
6.7% |
Interstitial Lung Disease |
5.4% |
Pruritus |
5.4% |
Pyrexia |
5.4% |
Rash |
5.2% |
White Blood Cell Count Decreased |
4.7% |
Anaemia |
4.5% |
Malaise |
4.5% |
Pneumonia |
4.5% |
Dizziness |
4.1% |
Renal Failure |
4.1% |
Hepatic Function Abnormal |
3.8% |
Urticaria |
3.8% |
Hypotension |
3.5% |
Flushing |
3.3% |
Paraesthesia |
3.3% |
Death |
3.1% |
|
Interacting |
Hypertension |
45.2% |
Product Used For Unknown Indication |
10.6% |
Pain |
5.8% |
Drug Use For Unknown Indication |
4.8% |
Erectile Dysfunction |
4.8% |
Alcoholism |
3.8% |
Blood Cholesterol |
2.9% |
Hiv Infection |
2.9% |
Benign Prostatic Hyperplasia |
1.9% |
Hyperphosphataemia |
1.9% |
Insomnia |
1.9% |
Major Depression |
1.9% |
Nasopharyngitis |
1.9% |
Prostatectomy |
1.9% |
Renal Cancer |
1.9% |
Sedative Therapy |
1.9% |
Blood Pressure Increased |
1.0% |
Cardiac Failure Congestive |
1.0% |
Hypothyroidism |
1.0% |
Myoclonic Epilepsy |
1.0% |
|
Hypotension |
17.6% |
Drug Interaction |
14.7% |
Renal Failure Acute |
11.8% |
Sudden Death |
8.8% |
Hyperkalaemia |
5.9% |
Renal Failure |
5.9% |
Shock |
5.9% |
Syncope |
5.9% |
Tremor |
5.9% |
Cardiac Arrest |
2.9% |
Drug Effect Decreased |
2.9% |
Dysgeusia |
2.9% |
Hypercalcaemia |
2.9% |
Hyponatraemia |
2.9% |
Pancreatitis Acute |
2.9% |
|